Vitamin D and Melanoma

Annals of Epidemiology

Volumn 19, Issue 7, 2009, Pages 455-461

  Egan, Kathleen M ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

1,25 dihydroxyvitamin D; Melanoma; Nonmelanoma skin cancer; UVB; VDR; Vitamin D; Vitamin D receptor

Indexed keywords

CALCITRIOL; SUNSCREEN; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

CANCER CELL CULTURE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CARCINOGENICITY; DAIRY PRODUCT; DIETARY INTAKE; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRUG MECHANISM; FOOD INTAKE; HUMAN; HYPERCALCEMIA; MELANOCYTE; MELANOMA; NONHUMAN; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SUN EXPOSURE; ULTRAVIOLET RADIATION;

HUMANS; MELANOMA; RECEPTORS, CALCITRIOL; SKIN NEOPLASMS; VITAMIN D; VITAMINS;

EID: 66449111134     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2009.01.005     Document Type: Review

References (71)

1. Lund L.P., and Timmins G.S. Melanoma, long wavelength ultraviolet and sunscreens: controversies and potential resolutions. Pharmacol Ther 114 (2007) 198-207 Epub 2007 Feb 15
2. Brannon PM, Yetley EA, Bailey RL, Picciano MF. Overview of the conference "Vitamin D and Health in the 21st Century: an Update". Am J Clin Nutr. 2008;88:483S-490S.
3. Oikawa A., and Nakayasu M. Stimulation of melanogenesis in cultured melanoma cells by calciferols. FEBS Lett 42 (1974) 32-35
4. Colston K., Colston M.J., Fieldsteel A.H., and Feldman D. 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines. Cancer Res 42 (1982) 856-859
5. Frampton R.J., Suva L.J., Eisman J.A., Findlay D.M., Moore G.E., Moseley J.M., et al. Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture. Cancer Res 42 (1982) 1116-1119
6. Colston K., Colston M.J., and Feldman D. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology 108 (1981) 1083-1086
7. Reichrath J., Rafi L., Rech M., Meineke V., Tilgen W., and Seifert M. No evidence for amplification of 25-hydroxyvitamin D-1alpha-OHase (1alpha-OHase) or 1,25-dihydroxyvitamin D-24-OHase (24-OHase) genes in malignant melanoma. J Steroid Biochem Mol Biol 89-90 (2004) 163-166
8. Osborne J.E., and Hutchinson P.E. Vitamin D and systemic cancer: is this relevant to malignant melanoma?. Br J Dermatol 147 (2002) 197-213
9. Albert D.M., Kumar A., Strugnell S.A., Darjatmoko S.R., Lokken J.M., Lindstrom M.J., et al. Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model. Arch Ophthalmol 122 (2004) 1365-1369
10. Reichrath J. Vitamin D and the skin: an ancient friend, revisited. Exp Dermatol 16 (2007) 618-625
11. Lehmann B. The vitamin D3 pathway in human skin and its role for regulation of biological processes. Photochem Photobiol 81 (2005) 1246-1251
12. Bikle D.D. Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens 17 (2008) 348-352
13. Sigmundsdottir H., Pan J., Debes G.F., Alt C., Habtezion A., Soler D., et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8 (2007) 285-293 Epub 2007 Jan 28
14. De Haes P., Garmyn M., Verstuyf A., De Clercq P., Vandewalle M., Degreef H., et al. 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. J Photochem Photobiol B 78 (2005) 141-148
15. Gupta R., Dixon K.M., Deo S.S., Holliday C.J., Slater M., Halliday G.M., et al. Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J Invest Dermatol 127 (2007) 707-715 Epub 2006 Dec 14
16. Beissert S., and Loser K. Molecular and cellular mechanisms of photocarcinogenesis. Photochem Photobiol 84 (2008) 29-34
17. Brash D.E., Ziegler A., Jonason A.S., Simon J.A., Kunala S., and Leffell D.J. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1 2 (1996 Apr) 136-142
18. Agar N.S., Halliday G.M., Barnetson R.S., Ananthaswamy H.N., Wheeler M., and Jones A.M. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci U S A 101 (2004) 4954-4959 Epub 2004 Mar 23
19. Halliday G.M., Agar N.S., Barnetson R.S., Ananthaswamy H.N., and Jones A.M. UV-A fingerprint mutations in human skin cancer. Photochem Photobiol 81 (2005) 3-8
20. Garland F.C., White M.R., Garland C.F., Shaw E., and Gorham E.D. Occupational sunlight exposure and melanoma in the U.S. Navy. Arch Environ Health 45 (1990) 261-267
21. Elwood J.M., and Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer 73 (1997) 198-203
22. Elwood J.M., Gallagher R.P., Hill G.B., and Pearson J.C. Cutaneous melanoma in relation to intermittent and constant sun exposure-the Western Canada Melanoma Study. Int J Cancer 35 (1985) 427-433
23. Beral V., and Robinson N. The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work. Br J Cancer 44 (1981) 886-891
24. Linet M.S., Malker H.S., Chow W.H., McLaughlin J.K., Weiner J.A., Stone B.J., et al. Occupational risks for cutaneous melanoma among men in Sweden. J Occup Environ Med 37 (1995) 1127-1135
25. Fears T.R., Bird C.C., Guerry IV D., Sagebiel R.W., Gail M.H., Elder D.E., et al. Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. Cancer Res 62 (2002) 3992-3996
26. Gervin C.M., McCulla A., Williams M., and Ouhtit A. Dysfunction of p53 in photocarcinogenesis. Front Biosci 8 (2003) s715-s717
27. Fecher L.A., Cummings S.D., Keefe M.J., and Alani R.M. Toward a molecular classification of melanoma. J Clin Oncol 25 (2007) 1606-1620
28. Maldonado J.L., Fridlyand J., Patel H., Jain A.N., Busam K., Kageshita T., et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95 (2003) 1878-1890
29. Curtin J.A., Fridlyand J., Kageshita T., Patel H.N., Busam K.J., Kutzner H., et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 353 (2005) 2135-2147
30. Poynter J.N., Elder J.T., Fullen D.R., Nair R.P., Soengas M.S., Johnson T.M., et al. BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res 16 (2006) 267-273
31. Wu J., Rosenbaum E., Begum S., and Westra W.H. Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis. Am J Dermatopathol 29 (2007) 534-537
32. Gorham E.D., Mohr S.B., Garland C.F., Chaplin G., and Garland F.C. Do sunscreens increase risk of melanoma in populations residing at higher latitudes?. Ann Epidemiol 17 (2007) 956-963
33. Diffey B. Sunscreen isn't enough. J Photochem Photobiol B 64 (2001) 105-108
34. Scherschun L., and Lim H.W. Photoprotection by sunscreens. Am J Clin Dermatol 2 (2001) 131-134
35. Farrerons J., Barnadas M., Rodriguez J., Renau A., Yoldi B., Lopez-Navidad A., et al. Clinically prescribed sunscreen (sun protection factor 15) does not decrease serum vitamin D concentration sufficiently either to induce changes in parathyroid function or in metabolic markers. Br J Dermatol 139 (1998) 422-427
36. Marks R., Foley P.A., Jolley D., Knight K.R., Harrison J., and Thompson S.C. The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. Arch Dermatol 131 (1995) 415-421
37. Matsuoka L.Y., Wortsman J., Hanifan N., and Holick M.F. Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol 124 (1988) 1802-1804
38. Matsuoka L.Y., Wortsman J., and Hollis B.W. Use of topical sunscreen for the evaluation of regional synthesis of vitamin D3. J Am Acad Dermatol 22 (1990) 772-775
39. Gallagher R.P., Spinelli J.J., and Lee T.K. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 14 (2005) 562-566
40. Veierod M.B., Weiderpass E., Thorn M., Hansson J., Lund E., Armstrong B., et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst 95 (2003) 1530-1538
41. Autier P. Perspectives in melanoma prevention: the case of sunbeds. Eur J Cancer 40 (2004) 2367-2376
42. Gerber B., Mathys P., Moser M., Bressoud D., and Braun-Fahrlander C. Ultraviolet emission spectra of sunbeds. Photochem Photobiol 76 (2002) 664-668
43. Lamberg-Allardt C. Vitamin D in foods and as supplements. Prog Biophys Mol Biol 92 (2006) 33-38 Epub 2006 Feb 28
44. Weinstock M.A., Stampfer M.J., Lew R.A., Willett W.C., and Sober A.J. Case-control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use. J Invest Dermatol 98 (1992) 809-811
45. Millen A.E., Tucker M.A., Hartge P., Halpern A., Elder D.E., Guerry IV D., et al. Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 13 (2004) 1042-1051
46. Bain C., Green A., Siskind V., Alexander J., and Harvey P. Diet and melanoma. An exploratory case-control study. Ann Epidemiol 3 (1993) 235-238
47. Stryker W.S., Stampfer M.J., Stein E.A., Kaplan L., Louis T.A., Sober A., et al. Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol 131 (1990) 597-611
48. Gallagher R.P., Elwood J.M., and Hill G.B. Risk factors for cutaneous malignant melanoma: the Western Canada Melanoma Study. Recent Results Cancer Res 102 (1986) 38-55
49. Hutchinson P.E., Osborne J.E., Lear J.T., Smith A.G., Bowers P.W., Morris P.N., et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 6 (2000) 498-504
50. Halsall J.A., Osborne J.E., Potter L., Pringle J.H., and Hutchinson P.E. A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibility and prognosis in malignant melanoma. Br J Cancer 91 (2004) 765-770
51. Han J., Colditz G.A., and Hunter D.J. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 28 (2007) 390-397
52. Li C., Liu Z., Zhang Z., Strom S.S., Gershenwald J.E., Prieto V.G., et al. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J Invest Dermatol 127 (2007) 276-280
53. Povey J.E., Darakhshan F., Robertson K., Bisset Y., Mekky M., Rees J., et al. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis 28 (2007) 1087-1093
54. Santonocito C., Capizzi R., Concolino P., Lavieri M.M., Paradisi A., Gentileschi S., et al. Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Br J Dermatol 156 (2007) 277-282
55. Whitfield G.K., Remus L.S., Jurutka P.W., Zitzer H., Oza A.K., Dang H.T., et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 177 (2001) 145-159
56. Carling T., Rastad J., Akerstrom G., and Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 83 (1998) 2255-2259
57. Cormier J.N., Xing Y., Ding M., Lee J.E., Mansfield P.F., Gershenwald J.E., et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 166 (2006) 1907-1914
58. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96 Epub 2008 Feb 20
59. Harris S.S. Vitamin D and African Americans. J Nutr 136 (2006) 1126-1129
60. Fears T.R., and Tucker M.A. Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst 97 (2005) 1789-1790 author reply 1791
61. Heenan P.J., English D.R., Holman C.D., and Armstrong B.K. Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981. Cancer 68 (1991) 2079-2087
62. Barnhill R.L., Fine J.A., Roush G.C., and Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 78 (1996) 427-432
63. Berwick M., Armstrong B.K., Ben-Porat L., Fine J., Kricker A., Eberle C., et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 97 (2005) 195-199
64. Larsen T.E., and Grude T.H. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 6. The relation of dermal solar elastosis to sex, age and survival of the patient and to localization, histological type and level of invasion of the tumour. Acta Pathol Microbiol Scand [A] 87A (1979) 361-366
65. Vollmer R.T. Solar elastosis in cutaneous melanoma. Am J Clin Pathol 128 (2007) 260-264
66. Dicker T.J., Kavanagh G.M., Herd R.M., Ahmad T., McLaren K.M., Chetty U., et al. A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group. Br J Dermatol 140 (1999) 249-254
67. Lachiewicz A.M., Berwick M., Wiggins C.L., and Thomas N.E. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER)program. Arch Dermatol 144 (2008) 515-521
68. Nürnberg B., Schadendorf D., Gärtner B., Pföhler C., Herrmann W., Tilgen W., et al. Progression of malignant melanoma is associated with reduced 25-hydroxyvitamin D serum levels. Exp Dermatol 17 (2008) 627
69. Nagpal S., Lu J., and Boehm M.F. Vitamin D analogs: mechanism of action and therapeutic applications. Curr Med Chem 8 (2001) 1661-1679 Review
70. Vieth R., Bischoff-Ferrari H., Boucher B.J., Dawson-Hughes B., Garland C.F., Heaney R.P., et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 85 (2007) 649-650 No abstract available. Erratum in: Am J Clin Nutr. 2007;86:809
71. Diffey B.L. Sunscreens and melanoma: the future looks bright. Br J Dermatol 153 (2005) 378-381